Cytocom

Winter Park, United States Founded: 2013 • Age: 13 yrs
Developer of therapeutic solutions for the treatment of infectious diseases

About Cytocom

Cytocom is a Healthcare company based in Winter Park (United States) founded in 2013. Cytocom has completed 1 acquisition, including ImQuest Life Sciences. Cytocom offers products and services including Blog Platform. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Viral. Its legal entity is Cytocom, Inc. Similar companies include Biogen, Moderna and Adaptive Biotechnologies; 3 of its 3 listed similar companies have raised funding.

Company details

Developer of therapeutic solutions for the treatment of infectious diseases. The drug pipeline includes CYTO-201 that helps in the treatment of a variety of viruses, CYTO-201 and CYTO-401 for the treatment of HIV and decreases the replication of the H1N1 influenza virus. Its products help in treating multiple diseases such as autoimmune diseases, infectious diseases, inflammatory diseases, cancers, and many more. It has developed CYTO-201 Lotrexon that helps to treat neurological disorders.

  • Headquarters Winter Park, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website cytocom.com
  • Social X
  • Legal Name Cytocom, Inc
Key Metrics

Products & Services of Cytocom

Cytocom offers a comprehensive portfolio of products and services, including Blog Platform.

Blog Platform
Content Platform

Site for accessing articles on diverse topics

Funding Insights of Cytocom

  • Total Rounds 1
  • Last Round Debt – Conventional β€” $2.28M
  • First Round $2.28M

    (Jul 2020)

All 1 funding rounds of Cytocom with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2020$2.28MDebt – Conventional––
–

People of Cytocom

8 people are tracked at Cytocom (4 in leadership, 4 in board & advisors).

NameRoleGroup
Allie Lopez
Senior Director of Clinical OperationsLeadership
Peter Aronstam
Chief Financial OfficerLeadership
Taunia Markvicka
Chief Operations OfficerLeadership
Kelly Wilson
Global Director of Program & Project ManagementLeadership
Fengping Shan
Scientific AdvisorBoard & advisors
Lea Verny
DirectorBoard & advisors
Randy Saluck
DirectorBoard & advisors
Steve Barbarick
DirectorBoard & advisors
Premium access

Complete people profiles for Cytocom

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Cytocom

Cytocom has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ImQuest Life Sciences.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
First-in-class drugs for infectious disease, cancer, and inflammation are developed.
imquestls.comFrederick, United States2005Jul 2020β€’β€’β€’β€’
Premium access

Complete acquisition details for Cytocom

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Cytocom

3 dated milestones of Cytocom across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Cytocom is founded.
  2. Funding First funding round of $2.3M.
  3. Acquisition Acquires ImQuest Life Sciences.

Similar companies to Cytocom

Cytocom has 3 listed similar companies in our database, 3 of them funded. They include Biogen, Moderna and Adaptive Biotechnologies.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
biogen.com1978Cambridge, United States$80M1
Therapies for neurodegenerative and immunology disorders are developed.
modernatx.com2010Cambridge, United States$2.78B1,312
mRNA-based therapeutics for diseases including cancer and infections are developed.
adaptivebiotech.com2009Seattle, United States$419.15M609
Clinical diagnostics and drug discovery for immune diseases are provided.
Premium access

Detailed similar companies of Cytocom

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Cytocom

Websites that share an audience with Cytocom (cytocom.com).

Similar websites

Websites whose visitors overlap most with Cytocom. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
easybib.co.uk
easybib.co.uk
100%
#1,818,141–
businesstalking.co.uk
businesstalking.co.uk
87%
–
glowmagazine.co.uk
glowmagazine.co.uk
78%
–
thegloworm.com
thegloworm.com
78%
–
hittechmarket.com
64%
View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 21 similar websites and full traffic analytics for Cytocom

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 21 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Infectious Diseases

3 companies that operate in the same segment as Cytocom (Infectious Diseases) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 87.11 M4,647
Therapeutics for drug-resistant bacterial infections are developed.
2013Cambridge, Massachusetts, United StatesUSD 114.7 MUSD 59.62 M32
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Cytocom

Premium access

Complete news archive for Cytocom

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cytocom

Cytocom was founded in 2013 and raised its 1st funding round 7 years after it was founded.

Cytocom is headquartered in Winter Park, United States. It is registered at Winter Park, Florida, United States.

Developer of therapeutic solutions for the treatment of infectious diseases. The drug pipeline includes CYTO-201 that helps in the treatment of a variety of viruses, CYTO-201 and CYTO-401 for the treatment of HIV and decreases the replication of the H1N1 influenza virus. Its products help in treating multiple diseases such as autoimmune diseases, infectious diseases, inflammatory diseases, cancers, and many more. It has developed CYTO-201 Lotrexon that helps to treat neurological disorders.

Cytocom's top competitors include Moderna, Adaptive Biotechnologies and Biogen.

Cytocom offers Blog Platform.

Cytocom has made 1 acquisition, including ImQuest Life Sciences.

Cytocom operates through Cytocom, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available